Pfizer filed a second lawsuit against Metsera and Novo Nordisk, alleging the weight-loss drug developers’ recent merger agreement would violate federal antitrust laws

3 days ago 3
The suit says the merger would solidify Novo Nordisk’s marketplace presumption arsenic a person successful the tract of obesity drugs by sidesplitting disconnected a smaller competitor.
Read Entire Article